Emmanuel H Demont

14PUBLICATIONS
46CO-AUTHORS
Molecular targetsBiologically active moleculesBiomaterialsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 30, 2025
BET Isoform Selectivity through Diverse Linkers for Bivalent Inhibitors: GSK785, a BRD2/4-Selective Bivalent BET Inhibitor.

Francesco Rianjongdee, Stephen J Atkinson, Paul Bamborough

|Aug 20, 2021
Optimization of Naphthyridones into Selective TATA-Binding Protein Associated Factor 1 (TAF1) Bromodomain Inhibitors.

Michael A Clegg, Natalie H Theodoulou, Paul Bamborough

|Aug 13, 2021
Discovery of a Novel Bromodomain and Extra Terminal Domain (BET) Protein Inhibitor, I-BET282E, Suitable for Clinical Progression.

Katherine L Jones, Dominic M Beaumont, Sharon G Bernard

|Jul 12, 2021
Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit.

Francesco Rianjongdee, Stephen J Atkinson, Chun-Wa Chung

Pageof 3